医学
乙酰唑胺
利尿剂
心力衰竭
噻嗪
重症监护医学
利尿剂
急性失代偿性心力衰竭
内科学
心脏病学
作者
Kassidy Veasaw,Uzair Mahmood,Tzvi Fishkin,William H. Frishman,Wilbert S. Aronow
标识
DOI:10.1097/crd.0000000000000615
摘要
The primary treatment for acute heart failure includes the use of intravenous loop diuretics to reduce congestion. Successful decongestion at the time of hospital discharge improves mortality and prevents rehospitalization in these patients. Loop diuretic therapy alone may not be enough for adequate decongestion, especially as diuretic resistance becomes more common. Other therapies include the addition of thiazide diuretics, though increasing evidence might suggest a better alternative to add-on therapy. In this review, we will discuss the new evidence for the use of the diuretic acetazolamide in acute heart failure.
科研通智能强力驱动
Strongly Powered by AbleSci AI